惠生國際(01340.HK)年度淨虧收窄80.9%至3662.5萬元
格隆匯7月1日丨惠生國際(01340.HK)公佈,截至2020年12月31日止年度,集團實現收益2966.3萬元人民幣(單位下同),同比增長424.5%;公司擁有人應占虧損3662.5萬元,同比收窄80.9%;每股基本及攤薄虧損4.16分,不派息。
公吿稱,虧損減少主要由於截至2020年12月31日止年度(i)物業、廠房及設備減值虧損減少約8680萬元;(ii)透過損益按公平值列賬的金融資產公平值變動所產生的虧損淨值減少約480萬元;及(iii)物業、廠房及設備的按金及預付款項的減值虧損減少約4400萬元;及(iv)生物資產的按金及預付款項的減值虧損減少約2800萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.